Physician
Hematology
Dr. Michael H. Veeder, MD
Michael H. Veeder, MD works in the field of Hematology. He studied medicine at Yale University School of Medicine. Yale University School of Medicine is a top medical college. Yale University School of Medicine is ranked 7 in research and 57 in primary care medicine He received 1 awards: "CMS Meaningful Use Stage 1 Certification". Michael Veeder is a published doctor. He has 32 publications published. The most current publication "A phase II study of high-dose cimetidine and the combination 5-fluorouracil, interferon alpha-2A, and leucovorin in advanced renal cell adenocarcinoma." Michael Veeder accepts Medicare payments and is registered with Medicare.gov.
Publications
- Long-term results of the treatment of patients with mantle cell lymphoma with cladribine (2-CDA) alone (95-80-53) or 2-CDA and rituximab (N0189) in the North Central C...
- Phase II study of gemcitabine plus cisplatin in patients with metastatic breast Cancer: a North Central Cancer Treatment Group Trial.
- Hematologic and cytogenetic spontaneous remission in Acute monocytic leukemia (FAB M5b) with trisomy 8.
- Phase III study of the Eastern Cooperative Oncology Group (ECOG 2597): inDuction chemotherapy followed by either standard thoracic radiotherapy or hyperfractionated ac...
- The role of radiotherapy in the management of operable locally advanced Breast carcinoma: results of a randomized trial by the Eastern Cooperative Oncology Group.
- A phase II trial of docetaxel and carboplatin as first-line chemotherapy for metastatic breast Cancer: NCCTG study N9932.
- Phase II study of 5-fluorouracil and leucovorin in recurrent primary Brain tumor.
- A prospective study of pulmonary function in patients receiving mitomycin.
- A phase III evaluation of a somatostatin analogue (octreotide) in the treatment of patients with asymptomatic advanced colon carcinoma. North Central Cancer Treatment ...
- Phase II trial of edatrexate in small cell lung Cancer.
- Sequencing and schedule effects of cisplatin plus etoposide in small-cell lung Cancer: results of a North Central Cancer Treatment Group randomized clinical trial.
- Transdermal clonidine for ameliorating tamoxifen-induced hot flashes.
- Randomized trial of cyclophosphamide, methotrexate, and 5-fluorouracil with or without estrogenic recruitment in women with metastatic breast Cancer.
- Inhibition of 5-fluorouracil-induced ocular irritation by ocular ice packs.
- Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon Carcinoma: a final report.
- Phase II trial of methotrexate, vinblastine, doxorubicin, and cisplatin in advanced/recurrent endometrial Carcinoma.
- Recurrent bacterial meningitis associated with C8 and IgA deficiency.
- Phase II studies of single-agent cimetidine and the combination N-phosphonacetyl-L-aspartate (NSC-224131) plus L-alanosine (NSC-153353) in advanced Malignant melanoma.
- Phase II study of the combination of carmustine and 6-thioguanine in advanced Malignant melanoma.
- Steroid-responsive pure red cell aplasia associated with natural killer cell Lymphocytosis.
- Weight change in women treated with adjuvant therapy or observed following mastectomy for node-positive breast Cancer.
- Bolus versus infusion regimens of etoposide and cisplatin in treatment of non-small cell lung Cancer: a study of the North Central Cancer Treatment group.
- Treatment of limited-stage small-cell lung Cancer with cyclophosphamide, doxorubicin, and vincristine with or without etoposide: a randomized trial of the North Centra...
- Inhibition of fluorouracil-induced stomatitis by oral cryotherapy.
- A randomized prospective assessment of recombinant leukocyte A human interferon with or without aspirin in advanced renal adenoCarcinoma.
- A phase III trial of mitomycin C alone versus mitomycin C, vinblastine, and cisplatin for metastatic squamous cell lung Carcinoma.
- Phase III clinical trial of the combination of cisplatin, dacarbazine, and carmustine with or without tamoxifen in patients with advanced Malignant melanoma.
- A randomized trial of tamoxifen alone or combined with octreotide in the treatment of women with metastatic Breast carcinoma.
- A phase II study of high-dose cimetidine and the combination 5-fluorouracil, interferon alpha-2A, and leucovorin in advanced renal cell adenoCarcinoma.
- Prospective evaluation of vitamin E for hot flashes in breast Cancer survivors.
- Mitoxantrone dose augmentation utilizing filgrastim support in combination with fixed-dose 5-fluorouracil and leucovorin in women with metastatic breast Cancer.
Schools
Yale University School Of Medicine
George Washington University Med Center
Farber Canc Center
Unc
Procedures Preformed
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Infectious Disease Medicine
- Medical Oncology
- Oncology
- Hematology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
George Washington University
-
Yale University School of Medicine
Drug Facts
| NPI NUMBER |
|
1568463305 |
| NPPES Provider LastName |
|
VEEDER |
| NPPES Provider FirstName |
|
MICHAEL |
| NPPES Provider ZIPCode |
|
616157822 |
| NPPES Provider State |
|
IL |
| Specialty Description |
|
Hematology/Oncology |
| Total Claim Count |
|
3488.0 |
| Distinct Opioid Count |
|
8.0 |
| Opioid Claim Count |
|
605.0 |
| Percent Opioid Claims |
|
17.35 |
Helpful Reviews
Give
Anonymous Review
Medicare Facts
| National Provider Identifier [NPI] |
1568463305 |
| Last Name Of The Provider |
VEEDER |
| First Name Of The Provider |
MICHAEL |
| View All |
|
Similar Doctors
Doctor Directory | TOS | twitter | FB | Angel | blog
This Doctor is OpenDoctor Recommended.